跳至主要内容
临床试验/CTRI/2017/12/010840
CTRI/2017/12/010840已完成未知

Evaluation of antioxidant effects of antiepileptic drugs in vivo

Self0 个研究点目标入组 39 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
Self
入组人数
39

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Newly diagnosed drug naive epileptic patients aged between 18-60 years of age of either gender
  • Patients who will be initiated on monotherapy with phenytoin or levetiracetam or oxcarbazepine
  • Patients who are willing to give informed consent

排除标准

  • Patients with history of psychiatric or progressive neurological disorders
  • Patients with history of other co morbid conditions like ischemic heart disease kidney disease liver disease thyroid disorders and other endocrinopathies
  • Patients with history of diseases that could influence the level of oxidative stress such as diabetes mellitus arterial hypertension malignancies recent surgery and trauma
  • Patients on drugs that influence the level of oxidative stress such as vitamins herbal medicines for the last 3 months
  • Pregnant and lactating women

研究者

发起方
Self

相似试验